Search Results - "Pagan Melendez, Fabiola"

Evaluating Ligand Modifications of the Titanocene and Auranofin Moieties for the Development of More Potent Anticancer Drugs by Fernández-Vega, Lauren, Ruiz Silva, Valeria A., Domínguez-González, Tania M., Claudio-Betancourt, Sebastián, Toro-Maldonado, Rafael E., Capre Maso, Luisa C., Sanabria Ortiz, Karina, Pérez-Verdejo, Jean A., Román González, Janeishly, Rosado-Fraticelli, Grecia T., Pagán Meléndez, Fabiola, Betancourt Santiago, Fabiola M., Rivera-Rivera, Daniel A., Martínez Navarro, Carlos, Bruno Chardón, Andrea C., Vera, Axel O., Tinoco, Arthur D.

“…Over time platinum-based anticancer drugs have dominated the market, but their side effects significantly impact the quality of life of patients. Alternative…”
Get full text

Abstract 3076: Characterization of an improved derivative of the Rac/PAK inhibitor EHop-016 in breast cancer by Castillo-Pichardo, Linette, Humphries-Bickley, Tessa, Forrestier-Roman, Ingrid, Borrero-Garcia, Luis, Pagan Melendez, Fabiola, Hernandez, Eliud, Vlaar, Cornelis, Cubano, Luis A., Dharmawardhane, Surangani

“…The expression and activities of the Rho GTPases Rac and Cdc42, and their downstream effector P21-activated kinase (PAK), have been correlated with metastatic…”
Get full text